Efficacy and Safety of LOX-1 Inhibition in Type 2 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of the American Heart Association
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Lectin-Like Oxidized Low-Density Lipoprotein Receptor 1 Inhibition in Type 2 Diabetes: Phase 1 Results
J Am Heart Assoc 2023 Jan 23;[EPub Ahead of Print], AL Vavere, M Sinsakul, EL Ongstad, Y Yang, V Varma, C Jones, J Goodman, VFS Dubois, AL Quartino, SK Karathanasis, L Abuhatzira, A Collén, C Antoniades, MJ Koren, R Gupta, RT GeorgeFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.